MNKD, TTM among premarket gainers

- iextrading.com Posted 5 years ago
ADMA Biologics (NASDAQ: ADMA ) +46% as FDA approves ADMA Biologics' ASCENIV. More news on: ADMA Biologics, Inc., Sangamo Therapeutics, Inc., Riot Blockchain, Inc., Stocks on the move, Read more …